A research team consisting of nurses, pharmacists and biomedical engineers at Northwestern Memorial Hospital recently published a study showing that while "smart pumps" are a necessary component to a safe medication system, they won’t generate meaningful improvements in patient safety until they are interfaced with other systems, such as the electronic health record, computerized provider order entry (CPOE), bar coded medication administration systems and pharmacy information systems. Smart pumps are intravenous (IV) pumps used to administer medication, consisting of software that checks programmed doses against preset limits specific to a drug and clinical location.
"The objectives of the study were to determine the actual types, frequency and severity of medication errors associated with IV pumps, and also determine if errors could have been prevented with the smart pump technology alone," says Marla Husch, RPh, lead author of the study. "We found that by itself the smart pump technology has little potential of improving care and reducing harm but by integrating the smart pump software with other information technology components, hospitals will have checks and balances in place to reduce the number of errors and further increase patient safety."
According to the study, errors occur during each step in the process of providing IV medication to hospital in-patients: prescribing, preparation and administration. An effective error reduction system must include a robust two-way communication so that the physician’s order can be verified in real time on the pump, and the pump can inform the hospital’s medical record system how much medication the patient has received.
Molly Rabinovitz | EurekAlert!
Team discovers how bacteria exploit a chink in the body's armor
20.01.2017 | University of Illinois at Urbana-Champaign
Rabies viruses reveal wiring in transparent brains
19.01.2017 | Rheinische Friedrich-Wilhelms-Universität Bonn
An important step towards a completely new experimental access to quantum physics has been made at University of Konstanz. The team of scientists headed by...
Yersiniae cause severe intestinal infections. Studies using Yersinia pseudotuberculosis as a model organism aim to elucidate the infection mechanisms of these...
Researchers from the University of Hamburg in Germany, in collaboration with colleagues from the University of Aarhus in Denmark, have synthesized a new superconducting material by growing a few layers of an antiferromagnetic transition-metal chalcogenide on a bismuth-based topological insulator, both being non-superconducting materials.
While superconductivity and magnetism are generally believed to be mutually exclusive, surprisingly, in this new material, superconducting correlations...
Laser-driving of semimetals allows creating novel quasiparticle states within condensed matter systems and switching between different states on ultrafast time scales
Studying properties of fundamental particles in condensed matter systems is a promising approach to quantum field theory. Quasiparticles offer the opportunity...
Among the general public, solar thermal energy is currently associated with dark blue, rectangular collectors on building roofs. Technologies are needed for aesthetically high quality architecture which offer the architect more room for manoeuvre when it comes to low- and plus-energy buildings. With the “ArKol” project, researchers at Fraunhofer ISE together with partners are currently developing two façade collectors for solar thermal energy generation, which permit a high degree of design flexibility: a strip collector for opaque façade sections and a solar thermal blind for transparent sections. The current state of the two developments will be presented at the BAU 2017 trade fair.
As part of the “ArKol – development of architecturally highly integrated façade collectors with heat pipes” project, Fraunhofer ISE together with its partners...
19.01.2017 | Event News
10.01.2017 | Event News
09.01.2017 | Event News
20.01.2017 | Awards Funding
20.01.2017 | Materials Sciences
20.01.2017 | Life Sciences